# Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir in Healthy Subjects

> **NCT00344123** · PHASE1 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 29 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Tipranavir/Ritonavir
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT00344123
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2016-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00344123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00344123, "Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir in Healthy Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00344123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*